These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 36140608

  • 1. The Diagnostic Value of Circulating Biomarkers and Role of Drug-Coated Balloons for In-Stent Restenosis in Patients with Peripheral Arterial Disease.
    Montelione N, Catanese V, Nenna A, Jawabra M, Verghi E, Loreni F, Nappi F, Lusini M, Mastroianni C, Jiritano F, Serraino GF, Mastroroberto P, Codispoti FA, Chello M, Spinelli F, Stilo F.
    Diagnostics (Basel); 2022 Sep 12; 12(9):. PubMed ID: 36140608
    [Abstract] [Full Text] [Related]

  • 2. Outcomes and Comparative Analysis of the Initial Results of Standard Balloon Angioplasty Versus Drug-Coated Balloons Alone Versus in Association With Laser-Excimer Atherectomy in the Treatment of Femoropopliteal Artery In-Stent Restenosis (INTACT).
    Ducasse E, Sapoval M, Brunet J, Commeau P, Goueffic Y, Sabatier J, Steinmetz E, Lermusiaux P, Rosset E, Caradu C.
    J Endovasc Ther; 2024 Apr 24; ():15266028241248333. PubMed ID: 38659343
    [Abstract] [Full Text] [Related]

  • 3. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
    Kokkinidis DG, Behan S, Jawaid O, Hossain P, Giannopoulos S, Singh GD, Laird JR, Valle JA, Waldo SW, Armstrong EJ.
    Catheter Cardiovasc Interv; 2020 Feb 15; 95(3):439-446. PubMed ID: 31816169
    [Abstract] [Full Text] [Related]

  • 4. Percutaneous Mechanical Atherectomy Plus Thrombectomy Using the Rotarex®S Device Followed by a Drug-Coated Balloon for the Treatment of Femoropopliteal Artery In-stent Restenosis: A Prospective Single-Center, Single-Arm Efficacy Trial (PERMIT-ISR Trial).
    Liu MY, Li W, Guo X, Zhang Z, Liu B, Yu H, Zhang Z, Chen X, Feng H.
    Front Surg; 2021 Feb 15; 8():671849. PubMed ID: 34595204
    [Abstract] [Full Text] [Related]

  • 5. Laser Atherectomy Combined With Drug-Coated Balloon Angioplasty Is Associated With Improved 1-Year Outcomes for Treatment of Femoropopliteal In-Stent Restenosis.
    Kokkinidis DG, Hossain P, Jawaid O, Alvandi B, Foley TR, Singh GD, Waldo SW, Laird JR, Armstrong EJ.
    J Endovasc Ther; 2018 Feb 15; 25(1):81-88. PubMed ID: 29219030
    [Abstract] [Full Text] [Related]

  • 6. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis.
    Giannopoulos S, Kokkinidis DG, Jawaid O, Behan S, Hossain P, Alvandi B, Foley TR, Singh GD, Waldo SW, Armstrong EJ.
    Cardiovasc Revasc Med; 2020 Jun 15; 21(6):771-778. PubMed ID: 31761634
    [Abstract] [Full Text] [Related]

  • 7. Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries: A single center experience (JET-SCE).
    Shammas NW, Shammas GA, Jones-Miller S, Shammas WJ, Bou-Dargham B, Shammas AN, Banerjee S, Rachwan RJ, Daher GE.
    Cardiovasc Revasc Med; 2018 Oct 15; 19(7 Pt A):771-777. PubMed ID: 30420096
    [Abstract] [Full Text] [Related]

  • 8. The safety and efficacy of different endovascular treatments for in-stent restenosis of the femoropopliteal artery: A network meta-analysis.
    He Z, Wang H, Lin F, Ding W, Chen K, Zhang Z.
    Vasc Med; 2022 Jun 15; 27(3):239-250. PubMed ID: 35164613
    [Abstract] [Full Text] [Related]

  • 9. Optical coherence tomography: guided therapy of in-stent restenosis for peripheral arterial disease.
    Lichtenberg MK, Carr JG, Golzar JA.
    J Cardiovasc Surg (Torino); 2017 Aug 15; 58(4):518-527. PubMed ID: 28382804
    [Abstract] [Full Text] [Related]

  • 10. Drug-Coated Balloon Angioplasty and Debulking for the Treatment of Femoropopliteal In-Stent Restenosis: A Systematic Review and Meta-Analysis.
    Tong Z, Guo L, Qi L, Cui S, Gao X, Li Y, Guo J, Gu Y.
    Biomed Res Int; 2020 Aug 15; 2020():3076346. PubMed ID: 32596293
    [Abstract] [Full Text] [Related]

  • 11. Debulking plus drug-coated balloon angioplasty versus drug-coated balloon angioplasty alone for femoropopliteal Tosaka III in-stent restenosis lesions.
    Li L, Tong Z, Cui S, Guo L.
    Wideochir Inne Tech Maloinwazyjne; 2023 Mar 15; 18(1):166-172. PubMed ID: 37064559
    [Abstract] [Full Text] [Related]

  • 12. Jetstream Atherectomy in Treating Femoropopliteal In-Stent Restenosis: Meta-Analysis of the JETSTREAM-ISR and JET-ISR Trials.
    Shammas NW, Jones-Miller S, Shammas GA, Shammas WJ.
    J Invasive Cardiol; 2020 Aug 15; 32(8):289-294. PubMed ID: 32737264
    [Abstract] [Full Text] [Related]

  • 13. Drug-Coated Balloon Angioplasty for Femoropopliteal In-Stent Restenosis.
    Cassese S, Wolf F, Ingwersen M, Kinstner CM, Fusaro M, Ndrepepa G, Ibrahim T, Ott I, Lammer J, Krankenberg H, Fusaro M.
    Circ Cardiovasc Interv; 2018 Dec 15; 11(12):e007055. PubMed ID: 30562083
    [Abstract] [Full Text] [Related]

  • 14. Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis.
    Giacoppo D, Alfonso F, Xu B, Claessen BEPM, Adriaenssens T, Jensen C, Pérez-Vizcayno MJ, Kang DY, Degenhardt R, Pleva L, Baan J, Cuesta J, Park DW, Kukla P, Jiménez-Quevedo P, Unverdorben M, Gao R, Naber CK, Park SJ, Henriques JPS, Kastrati A, Byrne RA.
    J Am Coll Cardiol; 2020 Jun 02; 75(21):2664-2678. PubMed ID: 32466881
    [Abstract] [Full Text] [Related]

  • 15. Benefits with drug-coated balloon as compared to a conventional revascularization strategy for the treatment of coronary and non-coronary arterial disease: a comprehensive meta-analysis of 45 randomized trials.
    Verdoia M, Negro F, Kedhi E, Suryapranata H, Marcolongo M, De Luca G.
    Vascul Pharmacol; 2021 Jun 02; 138():106859. PubMed ID: 33819672
    [Abstract] [Full Text] [Related]

  • 16. A systematic review and meta-analysis of the efficacy of debulking devices for in-stent restenosis of the femoropopliteal artery.
    Li X, Zhou M, Ding Y, Wang Y, Cai L, Shi Z.
    J Vasc Surg; 2020 Jul 02; 72(1):356-366.e5. PubMed ID: 32093910
    [Abstract] [Full Text] [Related]

  • 17. Diabetes mellitus and femoropopliteal in-stent restenosis.
    Voll F, Wolf F, Ingwersen M, Kinstner CM, Kufner S, Ibrahim T, Ott I, Krankenberg H, Fusaro M, Cassese S.
    Vasa; 2022 Jul 02; 51(4):247-255. PubMed ID: 35543439
    [Abstract] [Full Text] [Related]

  • 18. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
    Grotti S, Liistro F, Angioli P, Ducci K, Falsini G, Porto I, Ricci L, Ventoruzzo G, Turini F, Bellandi G, Bolognese L.
    J Endovasc Ther; 2016 Feb 02; 23(1):52-7. PubMed ID: 26511896
    [Abstract] [Full Text] [Related]

  • 19. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
    Jaff MR, Rosenfield K, Scheinert D, Rocha-Singh K, Benenati J, Nehler M, White CJ.
    Am Heart J; 2015 Apr 02; 169(4):479-85. PubMed ID: 25819854
    [Abstract] [Full Text] [Related]

  • 20. Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.
    Mehrotra S, Paramasivam G, Mishra S.
    Curr Cardiol Rep; 2017 Feb 02; 19(2):10. PubMed ID: 28185166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.